EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Impact of Conditioning Intensity on Survival in Adult Patients (< 65 Years) With Acute Myeloid Leukemia Receiving Antithymocyte Globulin and Post‐Transplantation Cyclophosphamide Based GVHD Prophylaxis

Ahmed Alnughmush iD, Ruah Alyamany, Mats Remberger iD, Ivan Pasic iD, Igor Novitzky-Basso, Arjun Datt Law iD, Wilson Lam, Dennis Dong Hwan Kim iD, Fotios V Michelis iD, Armin Gerbitz, Rajat Kumar iD, Jonas Mattsson und 1 weitere

European Journal of Haematology · 2025

DOI: 10.1111/ejh.14438 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Haematology, 2025. Verfasst von Ahmed Alnughmush und 12 weiteren Autor:innen. Beteiligte Einrichtung: Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Transplantation Conditioning, Cyclophosphamide, Graft vs Host Disease, Antilymphocyte Serum. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Myeloablative conditioning (MAC) for acute myeloid leukemia (AML) improves disease control by reducing relapse risk but is associated with higher non‐relapse mortality (NRM). Reduced‐intensity conditioning (RIC) aims to minimize toxicity but raises concerns about higher relapse rates. This study evaluates the impact of RIC versus MAC in AML patients under 65 years receiving GVHD prophylaxis with antithymocyte globulin, post‐transplant cyclophosphamide, and cyclosporine.

Methods

We retrospectively analyzed 322 AML patients undergoing allogeneic HCT with uniform GVHD prophylaxis. Propensity score matching (PSM) was applied to adjust for baseline differences.

Results

In the matched cohort, 2‐year overall survival (OS) did not differ significantly between RIC and MAC recipients (64.4% vs. 66.9%, p = 0.56). Relapse‐free survival (RFS) at 2 years was 65.0% for MAC and 52.7% for RIC ( p = 0.20). Two‐year NRM was 19.4% for MAC and 19.1% for RIC ( p = 0.84). Improved RFS was associated with non‐high‐risk DRI (HR: 0.39, p = 0.008), whereas conditioning intensity had no significant effect (HR: 0.98, p = 0.97). NRM was higher among patients with KPS < 90 (HR: 3.63, p = 0.01), with no significant impact observed from conditioning intensity (HR: 1.44, p = 0.43).

Conclusion

In a relatively younger cohort, conditioning intensity did not significantly impact survival, and MAC was not associated with increased NRM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transplantation ConditioningCyclophosphamideGraft vs Host DiseaseAntilymphocyte SerumLeukemia, Myeloid, AcuteHematopoietic Stem Cell TransplantationHumansMaleFemaleAdultMiddle AgedRetrospective StudiesYoung AdultTreatment OutcomeTransplantation, HomologousAgedImmunosuppressive Agents

Stichwörter der Autor:innen

AMLGVHD prophylaxisconditioningmyeloablativereduced intensitystem cell transplant

Substanzen

CyclophosphamideAntilymphocyte SerumImmunosuppressive Agents

Autor:innen und Institutionen

  • Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Department of Medicine, University of Toronto, Toronto, Canada.
  • Department of Hematology, Stem Cell Transplant and Cellular Therapy, Oncology Centre, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
  • Department of Medical Sciences, Uppsala University and KFUE, Uppsala University Hospital, Uppsala, Sweden.

ORCID-Profile: Ahmed Alnughmush, Mats Remberger, Ivan Pasic, Arjun Datt Law, Dennis Dong Hwan Kim, Fotios V Michelis, Rajat Kumar

Zitieren

APA

Alnughmush, A., Alyamany, R., Remberger, M., Pasic, I., Novitzky-Basso, I., Law, A. D., Lam, W., Kim, D. D. H., Michelis, F. V., Gerbitz, A., Kumar, R., Mattsson, J., & Viswabandya, A. (2025). Impact of Conditioning Intensity on Survival in Adult Patients (< 65 Years) With Acute Myeloid Leukemia Receiving Antithymocyte Globulin and Post‐Transplantation Cyclophosphamide Based GVHD Prophylaxis. European Journal of Haematology. https://doi.org/10.1111/ejh.14438

Vancouver

Alnughmush A, Alyamany R, Remberger M, Pasic I, Novitzky-Basso I, Law AD, et al. Impact of Conditioning Intensity on Survival in Adult Patients (< 65 Years) With Acute Myeloid Leukemia Receiving Antithymocyte Globulin and Post‐Transplantation Cyclophosphamide Based GVHD Prophylaxis. European Journal of Haematology. 2025. doi:10.1111/ejh.14438

BibTeX
@article{Alnughmush2025,
  author = {Alnughmush, Ahmed and Alyamany, Ruah and Remberger, Mats and Pasic, Ivan and Novitzky-Basso, Igor and Law, Arjun Datt and Lam, Wilson and Kim, Dennis Dong Hwan and Michelis, Fotios V and Gerbitz, Armin and Kumar, Rajat and Mattsson, Jonas and Viswabandya, Auro},
  title = {Impact of Conditioning Intensity on Survival in Adult Patients (< 65 Years) With Acute Myeloid Leukemia Receiving Antithymocyte Globulin and Post‐Transplantation Cyclophosphamide Based GVHD Prophylaxis},
  journal = {European Journal of Haematology},
  year = {2025},
  doi = {10.1111/ejh.14438}
}
Kostenlos starten →